PolyPid

Polymer Lipid Encapsulation Technology

Startup

PolyPid is a Petah Tikva-based startup in the Health Tech & Life Sciences sector, established in 2008. Polymer Lipid Encapsulation Technology. The company has raised a total of $239.24M across 14 funding rounds, currently at the Public stage. Key investors include Undisclosed Investor(s), Rosalind Advisors, DAFNA Capital Management, among 7 total investors. The company has 51-200 employees. Core technologies: Biologicals, Molecules.

With $239.24M in total funding, PolyPid is a Public-stage company operating in Health Tech & Life Sciences. The company follows a B2C/B2B2C business model. Product stage: Clinical Trial. The company holds 1 patent.

$239.24M
Raised
14
Rounds
7
Investors
4
Team
2008
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryBiologicalsMolecules
At a Glance
Investors

7 investors total

In the News

131 articles covered by sources including finance.yahoo.com, en.globes.co.il, www.globenewswire.com, www.biospace.com, hellogmb.com.

finance.yahoo.com · Oct 29, 2025
PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025
Read article ↗
Frequently Asked Questions
What does PolyPid do?

PolyPid is a late-stage biopharmaceutical company focused on improving surgical outcomes. Through locally administered, controlled, prolonged-release therapeutics, PolyPid’s proprietary PLEX (Polymer-Lipid Encapsulation matriX) technology pairs with active pharmaceutical ingredients to enable the precise delivery of drugs at optimal release rates over durations ranging from days to months. PolyPid’s lead product candidate, D-PLEX100, is in a phase 3 clinical trial for the prevention of abdominal colorectal surgical site infections. In addition, the company’s OncoPLEX is currently in preclinical stage testing for the treatment of solid tumors, beginning with glioblastomas.

How much funding has PolyPid raised?

PolyPid has raised $239.24M in total funding across 14 rounds. The company is currently at the Public stage. Key investors include Undisclosed Investor(s), Rosalind Advisors, DAFNA Capital Management.

What sector is PolyPid in?

PolyPid operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drug Delivery, with core technologies in Biologicals, Molecules. Target customers: Healthcare & Life Sciences, Life Sciences, Pharmaceuticals.

Where is PolyPid located?

PolyPid is based in HaSivim Street 18, Petah Tikva, Israel, Center District.

View Full Profile Classic View Website ↗